Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check20 days agoChange DetectedA banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to updates and FAQs.SummaryDifference0.8%

- Check27 days agoChange DetectedThe site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe footer now identifies the site as running revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check54 days agoChange DetectedThe record history shows the site revision tag updated from v3.6.6 to v3.7.0, indicating a software release for the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history and the previous v3.6.5 entry was removed, updating the historical record to reflect the latest published version.SummaryDifference0.1%

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.